2 bargain growth stocks with bullish catalysts

Should you invest in these two undervalued growth stocks?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In this article, I’m taking a look at two cheap small-cap stocks that have been under pressure but have real potential for the future.

Recovery play

TT Electronics (LSE: TTG) has had a tough few years as demand for its electronic components failed to meet earlier expectations. The company, which makes electronic components for the automotive, defence and aerospace industry, also faced operational problems with its new manufacturing facility in Romania and a number of delays in the launch of new product platforms. And as expected, these issues led to missed opportunities.

Fortunately, after nearly four years of restructuring, the company is showing some green shoots of recovery. Thanks to a combination of new product launches, cost savings and improving market conditions, TT Electronics reported double-digit percentage growth in revenues and earnings last year.

For the 2016 financial year, the company generated revenues of £569.9m, a 12% increase on the previous year. Meanwhile, pre-tax profits exceeded consensus analysts’ expectations, with the figure up 40% from last year to £26.9m, against City forecasts of £25.8m.

These results should reassure investors who had worried whether the company could turn around its fortunes after years of stagnation. Looking forward, the company advised that its order book remains sound, with revenues in line with the prior year on an organic basis.

Despite uncertain end-markets, we enter the year with good momentum in operational efficiency improvement and a robust order book, giving us confidence of making further progress in 2017,” said CEO Richard Tyson.

The business is doing particularly well in the automotive market, with management seeing a ramp-up of new contracts and increased volumes for both sensors and control solutions over the past year.

Its shares currently trade at a forward P/E of 14.7, with City analysts expecting the firm to grow its earnings by 13% this year and a further 10% in 2018. Based on these forecasts, TT shares seem attractively valued for a company with a double-digit growth outlook.

Improving demand

Things are also looking up for engineering firm Renold (LSE: RNO), which manufactures industrial chains and related power transmission products. The company had been under pressure from soft market conditions, but is benefitting from recent sterling weakness and improving demand in Europe.

It has yet to announce its results for the year to March 2017, but it expects reported revenue for the full year to be 11.1% ahead of last year’s figure of £165.2m, with adjusted operating profits in line with market expectations.

On the downside, Renold warned of rising costs as a result of increased sales and marketing expenditures, as well as challenging trading conditions in North America. Additionally, investors need to be mindful about the company’s substantial pension deficit. Its expected net liability for pension benefit obligations is more than £60m — that’s worth roughly half its market capitalisation, and means cash pension contributions going forward will likely significantly crimp free cash flow.

However, trading on a forward P/E of 11.6, its shares seem deeply undervalued and are certainly worth considering.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »